comparemela.com
Home
Live Updates
GT Biopharma Presents TriKE® Nanobody Pipeline (GTB-5550) Preclinical Multiple Myeloma Proof-of-Concept Data at 2022 EBMT Annual Meeting : comparemela.com
GT Biopharma Presents TriKE® Nanobody Pipeline (GTB-5550) Preclinical Multiple Myeloma Proof-of-Concept Data at 2022 EBMT Annual Meeting
/PRNewswire/ -- GT Biopharma, Inc. ("the Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based...
Related Keywords
Brisbane ,
Queensland ,
Australia ,
Prague ,
Praha ,
HlavnĂesto ,
Czech Republic ,
Aimee Merino ,
Corey Davis ,
David Castaneda ,
Gregory Berk ,
Bence Jones ,
Prnewswire Gt Biopharma Inc ,
Source Gt Biopharma Inc ,
Prague Congress Center ,
Exchange Commission ,
European Society For Blood ,
University Of Minnesota ,
Gt Biopharma Inc ,
Company Tri ,
Division Of Hematology ,
European Society ,
Marrow Transplantation Annual Meeting ,
Killer Engager ,
Assistant Professor ,
Chief Medical Officer ,
Mediated Killing ,
Incucyte Zoom ,
Tri Specific Killer Engager ,
Cell Based Immune ,
Board Number ,
Gt Biopharma ,
Nc ,
comparemela.com © 2020. All Rights Reserved.